K
4896.TK Pharma,Inc. Price (4896.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
11,604,600
(24.3702)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
K Pharma,Inc.Currency: JPY
| YEAR | 2021 | 2022 | 2023 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
0.00
+0% |
1,000,000,000.00
+0% |
||||||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 6,803,000.00 | 0.00 | 90,000,000.00 | ||||||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
-6,803,000.00
+0% |
0.00
+0% |
910,000,000.00
+0% |
||||||||||||||||
| Gross Profit Ratio | (0.00%) | (0.00%) | (0.91%) | ||||||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 134,519,000.00 | 163,971,000.00 | 0.00 | ||||||||||||||||
| General and Administrative | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Selling, General & Admin... | 67,971,000.00 | 169,382,000.00 | -1,000.00 | ||||||||||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Depreciation and Amortiz... | 6,803,000.00 | 31,293,000.00 | 1,000.00 | ||||||||||||||||
| Other Expenses | -4,000.00 | -45,000.00 | 543,944,000.00 | ||||||||||||||||
| Total Operating Expenses | 219,491,000.00 | 353,772,000.00 | 543,943,000.00 | ||||||||||||||||
| Cost and Exponses | 219,491,000.00 | 353,772,000.00 | 633,943,000.00 | ||||||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-219,491,000.00
+0% |
-353,772,000.00
+61% |
366,057,000.00
-203% |
||||||||||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (0.37%) | ||||||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 1,000.00 | 7,000.00 | 16,000.00 | ||||||||||||||||
| Interest Expenses | 0.00 | 0.00 | 11,849,000.00 | ||||||||||||||||
| Total Other Income/Exp... | -9,628,000.00 | -36,754,000.00 | -64,981,000.00 | ||||||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -222,315,000.00 | -322,479,000.00 | 366,058,000.00 | ||||||||||||||||
| EBITDA ratio | (0.00%) | (0.00%) | (0.37%) | ||||||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -229,119,000.00 | -390,526,000.00 | 301,076,000.00 | ||||||||||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (0.30%) | ||||||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -400,000.00 | 1,900,000.00 | 40,746,000.00 | ||||||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -228,718,000.00
+0% |
-392,427,000.00
+72% |
260,330,000.00
-166% |
||||||||||||||||
| Net Income Ratio | (0.00%) | (0.00%) | (0.26%) | ||||||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -19.79 | -42.06 | 22.43 | ||||||||||||||||
| Diluted EPS | -19.79 | -42.06 | 22.43 | ||||||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 11,559,000.00 | 9,330,690.00 | 11,604,600.00 | ||||||||||||||||
| Diluted Share Outstanding | 11,559,000.00 | 9,330,690.00 | 11,604,600.00 | ||||||||||||||||